Published in Eur J Epidemiol on July 06, 2014
The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol (2015) 1.61
Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One (2015) 0.85
Influence of BMI on short-term surgical outcome after colorectal cancer surgery: a study based on the Swedish national quality registry. Int J Colorectal Dis (2015) 0.82
Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis. Sci Rep (2015) 0.82
Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study. Eur J Epidemiol (2015) 0.82
The impact of obesity towards prostate diseases. Prostate Int (2015) 0.80
Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Res (2016) 0.76
Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center Diabetes Database. J Diabetes Investig (2016) 0.75
Excess weight as a risk factor common to many cancer sites: words of caution when interpreting meta-analytic evidence. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res (2016) 0.75
Genetically predicted high body mass index was associated with increased gastric cancer risk. Eur J Hum Genet (2017) 0.75
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69
Adipose tissue as an endocrine organ. J Clin Endocrinol Metab (2004) 11.94
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology (2003) 8.75
Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology (1995) 8.36
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81
Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 4.17
Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol (2000) 3.78
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27
A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer (2004) 2.96
Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr (2014) 2.95
Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control (2006) 2.64
Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem (2008) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Adiponectin and cancer: a systematic review. Br J Cancer (2006) 2.33
Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer (2007) 2.29
Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev (2006) 2.28
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer (2007) 2.23
Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev (2005) 2.16
Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst (2012) 2.13
Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care (2007) 2.04
Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol (2000) 1.95
Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol (2009) 1.87
Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80
Obesity and colorectal cancer risk in women. Gut (2002) 1.79
Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.77
Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer (2003) 1.71
Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol (2008) 1.64
Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer (2006) 1.64
Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control (2005) 1.55
Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol (2004) 1.54
Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci (2002) 1.51
Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative. Am J Epidemiol (2008) 1.48
Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord (2002) 1.41
Oxidative stress in a rat model of obesity-induced hypertension. Hypertension (2001) 1.41
Kidney in early atherosclerosis. Hypertension (2005) 1.39
Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol (2007) 1.32
Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer (2006) 1.31
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 1.28
Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas (2010) 1.26
A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer (2011) 1.25
Body mass index and risk of ovarian cancer. Cancer (2009) 1.23
Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev (2013) 1.23
Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol (1999) 1.22
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
Height, weight weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study. Cancer Causes Control (1997) 1.20
A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol (2006) 1.20
Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst (2012) 1.19
Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int (2005) 1.18
Body size, weight change, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.16
Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (Phila) (2012) 1.16
Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.16
Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev (2008) 1.15
Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2008) 1.12
Gastric cancer: epidemiologic aspects. Helicobacter (2013) 1.09
Body mass index and lung cancer risk in women. Epidemiology (2007) 1.08
Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer (2007) 1.06
Evidence for a link between IGF-I and cancer. Eur J Endocrinol (2004) 1.05
Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. Diabetes Care (1999) 0.99
Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol (2009) 0.98
Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer (2003) 0.96
A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control (2001) 0.95
Body mass and physical activity and risk of gastric cancer in a population-based cohort study in Norway. Cancer Epidemiol Biomarkers Prev (2008) 0.86
Height, weight and gastrointestinal cancer: a follow-up study in Norway. Eur J Cancer Prev (1999) 0.86
Is leptin sensitivity the link between smoking cessation and weight gain? Int J Obes Relat Metab Disord (1997) 0.83
The association of education with long-term weight change in the EPIC-PANACEA cohort. Eur J Clin Nutr (2012) 0.78
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science (2007) 43.16
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94
The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care (2003) 7.74
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care (2003) 5.48
Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol (2009) 5.37
European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27
Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet (2008) 4.84
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet (2008) 4.66
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol (2006) 4.54
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol (2005) 4.49
Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes (2003) 4.44
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes (2008) 4.20
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA (2003) 4.01
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol (2005) 3.95
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet (2010) 3.92
Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med (2004) 3.68
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med (2002) 3.61
Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet (2011) 3.56
Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol (2008) 3.28
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care (2007) 3.10
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J (2006) 2.94
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J (2004) 2.92
Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res (2005) 2.91
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat Genet (2013) 2.87
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes (2005) 2.82
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology (2005) 2.80
The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil (2005) 2.78
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63
Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes (2006) 2.58
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol (2010) 2.48
Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care (2007) 2.48
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes (2004) 2.46
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes (2004) 2.43
Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet (2003) 2.43
Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med (2002) 2.41
The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40
Prevalence of the metabolic syndrome among Omani adults. Diabetes Care (2003) 2.35
Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer (2005) 2.35
Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet (2012) 2.34
Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med (2007) 2.31